Join Dr. Ann Cavoukian, Executive Director for the Privacy and Big Data Institute of Ryerson University, and PHEMI CEO, Dr. Paul Terry, in a webinar hosted by HIMSS Media and PHEMI.Learn More
Learn how to avoid the “data swamp” in this paper
by PHEMI CEO, Dr. Paul Terry
PHEMI Central is a new class of data warehouse that uses big data technologies to handle any volume and variety of data, while providing advanced features for data management, privacy, and governance – all built right in.Take a Tour
Ingest any type of data, at speed
Transform, index, graph and catalog data into analytics-ready digital assets.
Access your virtual datasets on demand
Manage consent, data sharing agreements, de-identification and compliance automatically
Use a powerful metadata framework to manage data at the field-level automatically
PHEMI Named One of Canada’s Companies-to-Watch in the 2015 Deloitte Technology Fast 50™ Awards
VANCOUVER, BC, November 12, 2015 – PHEMI today announced it has received a 2015 Deloitte Technology Fast 50™ Award in the “Companies-to-Watch” category. Launched over 15 years ago, the Deloitte Technology Fast 50™ celebrates leadership, innovation and excellence in the Canadian technology sector.
Bringing Privacy, Security & Governance to Big Data
VANCOUVER, BC, September 22, 2015 – PHEMI, the company delivering privacy, security, and governance for big data, today introduced Zero Trust Data, an innovative, comprehensive approach to remove critical roadblocks standing in the way of enterprises aiming to become data-driven. A Zero Trust Data approach changes the way data is managed and secured, allowing companies to more effectively collect, share and protect data.
VANCOUVER, BC, September 22, 2015 – PHEMI, the company delivering privacy, security, governance and enterprise-grade management for big data, today announced that the Personalized Medicine Initiative (PMI), based in the Life Sciences Institute of the University of BC, has deployed PHEMI Central Big Data Warehouse to collect, store and manage genomic and clinical data for the Molecular You Corporation (MyCo) Pathfinder Project.